FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 353:2822-2823 December 29, 2005 Number 26 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited E-mail When Letters Appear PubMed Citation

To the Editor: Service et al. (July 21 issue)¹ recently reported on six patients with hyperinsulinemic hypoglycemia and nesidioblastosis after Roux-en-Y gastric bypass surgery. The authors postulated that the rapid presentation of nutrients in the duodenum stimulated excessive secretion of glucagon-like peptide 1, leading to islet-cell hypertrophy, proliferation, and neogenesis. This report prompted us to review the incidence of hyperinsulinemic hypoglycemia after laparoscopic adjustable gastric banding (LAGB), the most common bariatric procedure performed in Europe. This procedure effectively achieves gastric restriction and a durable weight loss in obese patients without permanently altering the intestinal anatomy, improves insulin resistance, and prevents . . . [Full Text of this Article]

This article has been cited by other articles:

• Goldfine, A. B., Mun, E. C., Devine, E., Bernier, R., Baz-Hecht, M., Jones, D. B., Schneider, B. E., Holst, J. J., Patti, M. E. (2007). Patients with Neuroglycopenia after Gastric Bypass Surgery Have Exaggerated Incretin and Insulin Secretory Responses to a Mixed Meal. J. Clin. Endocrinol. Metab. 92: 4678-4685 [Abstract] [Full Text]